Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: The AdVance study.

Date publication

mars 2019

Journal

European journal of haematology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr POCHON Cécile

Tous les auteurs :
González-Vicent M, Verna M, Pochon C, Chandak A, Vainorius E, Brundage T, Mozaffari E, Nichols G, Rao K

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/30418684

Résumé

Adenovirus (AdV) infections are potentially life-threatening for allogeneic hematopoietic stem cell transplant (allo-HCT) recipients. The AdVance study aimed to evaluate the incidence, management, and outcomes of AdV infections in European allo-HCT recipients.

Mots clés

DNA viruses, adenoviridae, antiviral agents, infection control, transplantation, virus diseases

Référence

Eur J Haematol. 2019 Mar;102(3):210-217